Free Trial
OTCMKTS:JUSHF

Jushi 5/7/2026 Earnings Report

Jushi logo
$0.51 +0.01 (+2.21%)
As of 03:59 PM Eastern

Jushi EPS Results

Actual EPS
N/A
Consensus EPS
-$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Jushi Revenue Results

Actual Revenue
N/A
Expected Revenue
$66.87 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Jushi Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Jushi Earnings Headlines

Elon Musk’s $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel
See More Jushi Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Jushi? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jushi and other key companies, straight to your email.

About Jushi

Jushi (OTCMKTS:JUSHF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing and sale of cannabis products across the United States. The company operates cultivation and processing facilities that support a diversified portfolio of consumer brands, serving both medical and adult-use markets. Through its in-house operations, Jushi produces hand-trimmed flower, pre-rolls, vaporizers, concentrates, edibles and topicals.

Jushi’s brand lineup includes Foray, Levia and Beboe, each designed to address distinct consumer preferences and consumption occasions. Foray focuses on more traditional flower and pre-roll offerings, while Levia was developed to deliver precision dosing through measured infusions. Beboe, known for its sleek packaging and high-potency formulations, targets the premium segment of the market. The company’s cultivation processes emphasize quality control and consistency, leveraging data and analytics to optimize yields and cannabinoid profiles.

The company’s retail footprint extends across multiple states, including key markets such as Pennsylvania, Connecticut, Ohio, California and Florida, among others. Jushi expanded its geographic presence in mid-2020 through the acquisition of PharmaCann, adding operational dispensaries and production assets in several new jurisdictions. This strategic move broadened Jushi’s market access, allowing the company to serve a wider patient and adult-use consumer base under state regulatory frameworks.

Founded in 2017 and led by Chief Executive Officer Jason Vedadi, Jushi emphasizes a culture of compliance and innovation. The executive team combines expertise in real estate, retail operations and consumer products to drive growth and operational efficiency. As the legal cannabis industry continues to evolve, Jushi positions itself to capitalize on changing regulations and increasing consumer acceptance.

View Jushi Profile